Multimodality standard of care treatment of resectable and borderline resectable pancreatic cancer

被引：3
|
作者：
Neoptolemos, John P. [1 ]
Ghaneh, Paula [2 ]
Hackert, Thilo [1 ]
机构：
[1] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany
[2] Univ Liverpool, Inst Syst Mol & Integrat Biol, Dept Clin Canc Med, Liverpool, Merseyside, England
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2021年 / 10卷 / 05期
关键词：
GEMCITABINE; THERAPY;
D O I：
10.21037/hbsn-21-131
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：714 / 716
页数：3
相关论文
共 50 条
  • [31] Neoadjuvant therapy in borderline resectable and resectable pancreatic cancer.
    Dhamija, Kriti
    Awuah, Kojo-Frimpong B.
    Marwaha, Alexander
    Kharoud, Harmeet
    Monga, Dulabh K.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 735 - 735
  • [32] Multimodality therapy for borderline resectable pancreatic cancer: A single-institution experience
    Pimiento, Jose Mario
    Hutchinson, Tai
    Weber, Jill M.
    Patel, Manish R.
    Hodul, Pamela Joy
    Chuong, Michael D.
    Springett, Gregory M.
    Hoffe, Sarah E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [33] Management of Borderline Resectable Pancreatic Cancer
    Lal, Alysandra
    Christians, Kathleen
    Evans, Douglas B.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (02) : 359 - +
  • [34] Management of borderline resectable pancreatic cancer
    Amit Mahipal
    Jessica Frakes
    Sarah Hoffe
    Richard Kim
    World Journal of Gastrointestinal Oncology, 2015, (10) : 241 - 249
  • [35] Management of borderline resectable pancreatic cancer
    Mahipal, Amit
    Frakes, Jessica
    Hoffe, Sarah
    Kim, Richard
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 7 (10) : 241 - 249
  • [36] Management of Borderline Resectable Pancreatic Cancer
    Katz, Matthew H. G.
    Crane, Christopher H.
    Varadhachary, Gauri
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (02) : 105 - 112
  • [37] Management of Borderline Resectable Pancreatic Cancer
    Toesca, Diego A. S.
    Koong, Amanda J.
    Poultsides, George A.
    Visser, Brendan C.
    Haraldsdottir, Sigurdis
    Koong, Albert C.
    Chang, Daniel T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1155 - 1174
  • [38] Current Value of Perioperative Therapies for Resectable or Borderline Resectable Pancreatic Cancer
    Murakami, Yuki
    Sakamoto, Teruhisa
    Hanaki, Takehiko
    Tokuyasu, Naruo
    Fujiwara, Yoshiyuki
    YONAGO ACTA MEDICA, 2023, 66 (02) : 202 - 207
  • [39] Optimal Treatment for Octogenarians With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Satoi, S.
    Yamamoto, T.
    Uchida, K.
    Fujii, T.
    Kin, T.
    Asano, T.
    Hanada, K.
    Itoi, T.
    Murakami, Y.
    Igarashi, H.
    Eguchi, H.
    Kuroki, T.
    Shimizu, Y.
    Tani, M.
    Tanno, S.
    Tsuji, Y.
    Hirooka, Y.
    Masamune, A.
    Mizumoto, K.
    Shimokawa, T.
    Yamaue, H.
    Okazaki, K.
    PANCREAS, 2019, 48 (10) : 1516 - 1517
  • [40] Characteristics and Outcomes of Borderline Resectable Pancreatic Cancer Compared with Resectable Disease
    Thomas, A.
    Melling, J.
    Jackson, R.
    Whelan, P.
    Sykes, P.
    Jones, O.
    Smith, R.
    Campbell, F.
    Evans, J.
    Raraty, M.
    Halloran, C.
    Sutton, R.
    Neoptolemos, J.
    Ghaneh, P.
    PANCREAS, 2013, 42 (08) : 1386 - 1386
12345